REGENXBIO INC (RGNX:NASDAQ)
$9.34 0.23 (2.5247%)
Analysed REGENXBIO INC (RGNX:NASDAQ) News Sources
OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead
22-04-2026
yahoo.com
Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
22-04-2026
yahoo.com
Denali Solved A Major Challenge In Treating A Rare Genetic Disease. Now, Shares Are Flying.
01-04-2026
yahoo.com
Denali Jumps, Pulling Regenxbio Higher, On Early FDA Approval
25-03-2026
yahoo.com
Mixed signals cloud the orphan drug market
25-03-2026
pharmavoice.com
Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data
20-03-2026
yahoo.com
OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch
20-03-2026
yahoo.com
REGENXBIO REPORTS NEW POSITIVE INTERIM DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202
11-03-2026
yahoo.com
uniQure stock surges 36% on FDA official’s departure
09-03-2026
yahoo.com
REGENXBIO Q4 Earnings Call Highlights
06-03-2026
marketbeat.com
What is the current price of REGENXBIO INC (RGNX:NASDAQ)?
The current price of REGENXBIO INC (RGNX:NASDAQ) is $9.34.
REGENXBIO INC (RGNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of REGENXBIO INC (RGNX:NASDAQ) since the previous trading day is $0.23.
REGENXBIO INC (RGNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of REGENXBIO INC (RGNX:NASDAQ) since the previous trading day is 2.5247%.
What is the most recent average sentiment score for REGENXBIO INC (RGNX:NASDAQ)?
The most recent average sentiment score for REGENXBIO INC (RGNX:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for REGENXBIO INC (RGNX:NASDAQ)?
The most recent sentiment for REGENXBIO INC (RGNX:NASDAQ) is .
SEC-8K** Filing Available For REGENXBIO INC (RGNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.